首页 > 最新文献

Acta Biomaterialia最新文献

英文 中文
Lipopolymer/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia 针对FLT3突变急性髓性白血病化疗的最佳分子和功能反应而设计的脂质聚合物/siRNA复合物
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.08.053
Aysha S. Ansari , Cezary Kucharski , Remant KC , Daniel Nisakar , Ramea Rahim , Xiaoyan Jiang , Joseph Brandwein , Hasan Uludağ
Approximately 25% of newly diagnosed AML patients display an internal tandem duplication (ITD) in the fms-like tyrosine kinase 3 (FLT3) gene. Although both multi-targeted and FLT3 specific tyrosine kinase inhibitors (TKIs) are being utilized for clinical therapy, drug resistance, short remission periods, and high relapse rates are challenges that still need to be tackled. RNA interference (RNAi), mediated by short interfering RNA (siRNA), presents a mechanistically distinct therapeutic platform with the potential of personalization due to its gene sequence-driven mechanism of action. This study explored the use of a non-viral approach for delivery of FLT3 siRNA (siFLT3) in FLT3-ITD positive AML cell lines and primary cells as well as the feasibility of combining this treatment with drugs currently used in the clinic. Treatment of AML cell lines with FLT3 siRNA nanocomplexes resulted in prominent reduction in cell proliferation rates and induction of apoptosis. Quantitative analysis of relative mRNA transcript levels revealed downregulation of the FLT3 gene, which was accompanied by a similar decline in FLT3 protein levels. Moreover, an impact on leukemic stem cells was observed in a small pool of primary AML samples through significantly reduced colony numbers. An absence of a molecular response post-treatment with lipopolymer/siFLT3 complexes in peripheral blood mononuclear cells, obtained from healthy individuals, denoted a passive selectivity of the complexes towards malignant cells. The effect of combining lipopolymer/siFLT3 complexes with daunorubucin and FLT3 targeting TKI gilteritinib led to a significant augmentation of anti-leukemic activity. These findings demonstrate the promising potential of RNAi implemented with lipopolymer complexes for AML molecular therapy. The study prospectively supports the addition of RNAi therapy to current treatment modalities available to target the heterogeneity prevalent in AML.

Statement of significance

We show that a clinically validated target, the FLT3 gene, can be eradicated in leukemia cells using non-viral RNAi. We validated these lipopolymers as effective vehicles to deliver nucleic acids to leukemic cells. The potency of the lipopolymers was superior to that of the ‘gold-standard’ delivery agent, lipid nanoparticles (LNPs), which are not effective in leukemia cells at clinically relevant doses. Mechanistic studies were undertaken to probe structure-function relationships for effective biomaterial formulations. Cellular and molecular responses to siRNA treatment have been characterized in cell models, including leukemia patient-derived cells. The use of the siRNA therapy with clinically used chemotherapy was demonstrated.
在新诊断出的急性髓细胞性白血病患者中,约有 25% 的患者体内的 fms 样酪氨酸激酶 3(FLT3)基因存在内部串联重复(ITD)。尽管多靶点和FLT3特异性酪氨酸激酶抑制剂(TKIs)已被用于临床治疗,但耐药性、缓解期短和复发率高仍是亟待解决的难题。由短干扰 RNA(siRNA)介导的 RNA 干扰(RNAi)因其基因序列驱动的作用机制,提供了一种机制独特的治疗平台,具有个性化治疗的潜力。本研究探讨了在 FLT3-ITD 阳性 AML 细胞系和原代细胞中使用非病毒方法递送 FLT3 siRNA(siFLT3),以及将这种疗法与目前临床上使用的药物相结合的可行性。用 FLT3 siRNA 纳米复合物处理急性髓细胞性白血病细胞系可显著降低细胞增殖率并诱导细胞凋亡。对相对 mRNA 转录水平的定量分析显示,FLT3 基因发生了下调,同时 FLT3 蛋白水平也出现了类似的下降。此外,在一小部分原发性急性髓细胞性白血病样本中,通过显著减少集落数量观察到了对白血病干细胞的影响。健康人的外周血单核细胞在接受脂质聚合物/siFLT3复合物处理后没有出现分子反应,这表明复合物对恶性细胞具有被动选择性。将脂质聚合物/siFLT3复合物与daunorubucin和FLT3靶向TKI吉特替尼结合使用,可显著增强抗白血病活性。这些研究结果表明,将RNAi与脂质聚合物复合物用于急性髓细胞性白血病分子治疗具有广阔的前景。该研究前瞻性地支持将RNAi疗法添加到目前的治疗模式中,以针对急性髓细胞性白血病中普遍存在的异质性。意义说明:我们的研究表明,利用非病毒 RNAi 技术可以根除白血病细胞中的临床验证靶点 FLT3 基因。我们验证了这些脂质聚合物是向白血病细胞递送核酸的有效载体。脂质聚合物的效力优于 "黄金标准 "递送剂--脂质纳米颗粒(LNPs),后者在临床相关剂量下对白血病细胞无效。研究人员进行了机理研究,以探究有效生物材料配方的结构-功能关系。在细胞模型(包括白血病患者衍生细胞)中对 siRNA 治疗的细胞和分子反应进行了表征。研究还证明了 siRNA 疗法与临床化疗的结合使用。
{"title":"Lipopolymer/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia","authors":"Aysha S. Ansari ,&nbsp;Cezary Kucharski ,&nbsp;Remant KC ,&nbsp;Daniel Nisakar ,&nbsp;Ramea Rahim ,&nbsp;Xiaoyan Jiang ,&nbsp;Joseph Brandwein ,&nbsp;Hasan Uludağ","doi":"10.1016/j.actbio.2024.08.053","DOIUrl":"10.1016/j.actbio.2024.08.053","url":null,"abstract":"<div><div>Approximately 25% of newly diagnosed AML patients display an internal tandem duplication (ITD) in the <em>fms-like tyrosine kinase 3</em> (<em>FLT3</em>) gene. Although both multi-targeted and FLT3 specific tyrosine kinase inhibitors (TKIs) are being utilized for clinical therapy, drug resistance, short remission periods, and high relapse rates are challenges that still need to be tackled. RNA interference (RNAi), mediated by short interfering RNA (siRNA), presents a mechanistically distinct therapeutic platform with the potential of personalization due to its gene sequence-driven mechanism of action. This study explored the use of a non-viral approach for delivery of FLT3 siRNA (siFLT3) in FLT3-ITD positive AML cell lines and primary cells as well as the feasibility of combining this treatment with drugs currently used in the clinic. Treatment of AML cell lines with FLT3 siRNA nanocomplexes resulted in prominent reduction in cell proliferation rates and induction of apoptosis. Quantitative analysis of relative mRNA transcript levels revealed downregulation of the FLT3 gene, which was accompanied by a similar decline in FLT3 protein levels. Moreover, an impact on leukemic stem cells was observed in a small pool of primary AML samples through significantly reduced colony numbers. An absence of a molecular response post-treatment with lipopolymer/siFLT3 complexes in peripheral blood mononuclear cells, obtained from healthy individuals, denoted a passive selectivity of the complexes towards malignant cells. The effect of combining lipopolymer/siFLT3 complexes with daunorubucin and FLT3 targeting TKI gilteritinib led to a significant augmentation of anti-leukemic activity. These findings demonstrate the promising potential of RNAi implemented with lipopolymer complexes for AML molecular therapy. The study prospectively supports the addition of RNAi therapy to current treatment modalities available to target the heterogeneity prevalent in AML.</div></div><div><h3>Statement of significance</h3><div>We show that a clinically validated target, the <em>FLT3</em> gene, can be eradicated in leukemia cells using non-viral RNAi. We validated these lipopolymers as effective vehicles to deliver nucleic acids to leukemic cells. The potency of the lipopolymers was superior to that of the ‘gold-standard’ delivery agent, lipid nanoparticles (LNPs), which are not effective in leukemia cells at clinically relevant doses. Mechanistic studies were undertaken to probe structure-function relationships for effective biomaterial formulations. Cellular and molecular responses to siRNA treatment have been characterized in cell models, including leukemia patient-derived cells. The use of the siRNA therapy with clinically used chemotherapy was demonstrated.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 297-314"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A photo-modulated nitric oxide delivering hydrogel for the accelerated healing of biofilm infected chronic wounds 用于加速生物膜感染慢性伤口愈合的光调节一氧化氮输送水凝胶。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.017
Huifang Ma , Tengjiao Wang , Gangfeng Li , Jiaheng Liang , Jianhong Zhang , Yang Liu , Wenbin Zhong , Peng Li
Biofilm infection and impaired healing of chronic wounds are posing tremendous challenges in clinical practice. In this study, we presented a versatile antimicrobial hydrogel capable of delivering nitric oxide (NO) in a controllable manner to dissipate biofilms, eliminate microorganisms, and promote the healing of chronic wounds. This hydrogel was constructed by Schiff-base crosslinking of oxidized dextran and antimicrobial peptide ε-poly-lysine, further encapsulating photothermal nanoparticles bearing NO donor. This hydrogel could continuously and slowly release NO, effectively dissipating biofilms, and promoting the proliferation of mouse fibroblasts and the migration of endothelial cells. Upon exposure to NIR laser irradiation, the hydrogel generated hyperthermia and rapidly released NO, resulting in the efficient elimination of a broad spectrum of drug-resistant Gram-positive/negative bacterial and fungal biofilms through the synergistic effects of NO, photothermal therapy, and the antibacterial peptide. Notably, the hydrogel demonstrated exceptional in vivo therapeutic outcomes in accelerating the healing process of mice diabetic wounds infected with methicillin-resistant Staphylococcus aureus by successfully eliminating biofilm infection, regulating inflammation, and facilitating angiogenesis and collagen deposition. Overall, this proposed hydrogel shows great promise in accommodating the various demands of the complex repair process of chronic wounds infected with biofilms.

Statement of significance

The presence of biofilm infections and underlying dysfunctions in the healing process made chronic wound become stuck in the inflammation stage and difficult to heal. This work developed a NIR laser-modulated three-stage NO-releasing versatile antimicrobial hydrogel (DEPN) exhibiting good therapeutic efficacy for chronic wound. This DEPN hydrogel could inherently and slowly released NO to disperse biofilm. Upon NIR laser irradiation, the DEPN hydrogel generated hyperthermia and induced a rapid burst release of NO effectively eliminating a broad spectrum of drug-resistant bacterial and fungal biofilms. Subsequently, the DEPN hydrogel continually release NO slowly to promote the tissue remolding. This DEPN hydrogel displays great potential in treatment of chronic wounds infected with biofilm.
生物膜感染和慢性伤口愈合障碍给临床实践带来了巨大挑战。在这项研究中,我们提出了一种多功能抗菌水凝胶,它能以可控方式输送一氧化氮(NO),以消散生物膜、清除微生物并促进慢性伤口愈合。这种水凝胶是由氧化葡聚糖和抗菌肽ε-聚赖氨酸通过席夫碱交联构建而成,并进一步包裹了含有一氧化氮供体的光热纳米粒子。这种水凝胶能持续、缓慢地释放 NO,有效驱散生物膜,促进小鼠成纤维细胞的增殖和内皮细胞的迁移。在近红外激光照射下,水凝胶产生高热并迅速释放 NO,通过 NO、光热疗法和抗菌肽的协同作用,有效消除了多种耐药革兰氏阳性/阴性细菌和真菌生物膜。值得注意的是,这种水凝胶通过成功消除生物膜感染、调节炎症、促进血管生成和胶原蛋白沉积,在加速感染了耐甲氧西林金黄色葡萄球菌的小鼠糖尿病伤口愈合过程中显示出卓越的体内治疗效果。总之,这种拟议的水凝胶在适应受生物膜感染的慢性伤口复杂修复过程的各种需求方面显示出巨大的前景。意义说明生物膜感染的存在和愈合过程中的潜在功能障碍使慢性伤口陷入炎症阶段,难以愈合。这项研究开发了一种近红外激光调制的三级氮释放多功能抗菌水凝胶(DEPN),对慢性伤口具有良好的治疗效果。这种 DEPN 水凝胶本身可缓慢释放 NO 以驱散生物膜。在近红外激光照射下,DEPN 水凝胶会产生高热,并诱导 NO 快速爆发释放,从而有效消除多种耐药细菌和真菌生物膜。随后,DEPN 水凝胶继续缓慢释放 NO,促进组织重塑。这种 DEPN 水凝胶在治疗受生物膜感染的慢性伤口方面显示出巨大的潜力。
{"title":"A photo-modulated nitric oxide delivering hydrogel for the accelerated healing of biofilm infected chronic wounds","authors":"Huifang Ma ,&nbsp;Tengjiao Wang ,&nbsp;Gangfeng Li ,&nbsp;Jiaheng Liang ,&nbsp;Jianhong Zhang ,&nbsp;Yang Liu ,&nbsp;Wenbin Zhong ,&nbsp;Peng Li","doi":"10.1016/j.actbio.2024.09.017","DOIUrl":"10.1016/j.actbio.2024.09.017","url":null,"abstract":"<div><div>Biofilm infection and impaired healing of chronic wounds are posing tremendous challenges in clinical practice. In this study, we presented a versatile antimicrobial hydrogel capable of delivering nitric oxide (NO) in a controllable manner to dissipate biofilms, eliminate microorganisms, and promote the healing of chronic wounds. This hydrogel was constructed by Schiff-base crosslinking of oxidized dextran and antimicrobial peptide ε-poly-lysine, further encapsulating photothermal nanoparticles bearing NO donor. This hydrogel could continuously and slowly release NO, effectively dissipating biofilms, and promoting the proliferation of mouse fibroblasts and the migration of endothelial cells. Upon exposure to NIR laser irradiation, the hydrogel generated hyperthermia and rapidly released NO, resulting in the efficient elimination of a broad spectrum of drug-resistant Gram-positive/negative bacterial and fungal biofilms through the synergistic effects of NO, photothermal therapy, and the antibacterial peptide. Notably, the hydrogel demonstrated exceptional <em>in vivo</em> therapeutic outcomes in accelerating the healing process of mice diabetic wounds infected with methicillin-resistant <em>Staphylococcus aureus</em> by successfully eliminating biofilm infection, regulating inflammation, and facilitating angiogenesis and collagen deposition. Overall, this proposed hydrogel shows great promise in accommodating the various demands of the complex repair process of chronic wounds infected with biofilms.</div></div><div><h3>Statement of significance</h3><div>The presence of biofilm infections and underlying dysfunctions in the healing process made chronic wound become stuck in the inflammation stage and difficult to heal. This work developed a NIR laser-modulated three-stage NO-releasing versatile antimicrobial hydrogel (DEPN) exhibiting good therapeutic efficacy for chronic wound. This DEPN hydrogel could inherently and slowly released NO to disperse biofilm. Upon NIR laser irradiation, the DEPN hydrogel generated hyperthermia and induced a rapid burst release of NO effectively eliminating a broad spectrum of drug-resistant bacterial and fungal biofilms. Subsequently, the DEPN hydrogel continually release NO slowly to promote the tissue remolding. This DEPN hydrogel displays great potential in treatment of chronic wounds infected with biofilm.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 169-183"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A viscoelastic constitutive framework for aging muscular and elastic arteries 老化肌肉和弹性动脉的粘弹性构成框架
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.021
Will Zhang , Majid Jadidi , Sayed Ahmadreza Razian , Gerhard A. Holzapfel , Alexey Kamenskiy , David A. Nordsletten
The evolution of arterial biomechanics and microstructure with age and disease plays a critical role in understanding the health and function of the cardiovascular system. Accurately capturing these adaptative processes and their effects on the mechanical environment is critical for predicting arterial responses. This challenge is exacerbated by the significant differences between elastic and muscular arteries, which have different structural organizations and functional demands. In this study, we aim to shed light to these adaptive processes by comparing the viscoelastic mechanics of autologous thoracic aortas (TA) and femoropopliteal arteries (FPA) in different age groups. We have extended our fractional viscoelastic framework, originally developed for FPA, to both types of arteries. To evaluate this framework, we analyzed experimental mechanical data from TA and FPA specimens from 21 individuals aged 13 to 73 years. Each specimen was subjected to a multi-ratio biaxial mechanical extension and relaxation test complemented by bidirectional histology to quantify the structural density and microstructural orientations. Our new constitutive model accurately captured the mechanical responses and microstructural differences of the tissues and closely matched the experimentally measured densities. It was found that the viscoelastic properties of collagen and smooth muscle cells (SMCs) in both the FPA and TA remained consistent with age, but the viscoelasticity of the SMCs in the FPA was twice that of the TA. Additionally, changes in collagen nonlinearity with age were similar in both TA and FPA. This model provides valuable insights into arterial mechanophysiology and the effects of pathological conditions on vascular biomechanics.

Statement of significance

Developing durable treatments for arterial diseases necessitates a deeper understanding of how mechanical properties evolve with age in response to mechanical environments. In this work, we developed a generalized viscoelastic constitutive model for both elastic and muscular arteries and analyzed both the thoracic aorta (TA) and the femoropopliteal artery (FPA) from 21 donors aged 13 to 73. The derived parameters correlate well with histology, allowing further examination of how viscoelasticity evolves with age. Correlation between the TA and FPA of the same donors suggest that the viscoelasticity of the FPA may be influenced by the TA, necessitating more detailed analysis. In summary, our new model proves to be a valuable tool for studying arterial mechanophysiology and exploring pathological impacts.
动脉生物力学和微观结构随年龄和疾病的演变对了解心血管系统的健康和功能起着至关重要的作用。准确捕捉这些适应过程及其对机械环境的影响对于预测动脉反应至关重要。由于弹性动脉和肌肉动脉具有不同的结构组织和功能需求,两者之间的显著差异加剧了这一挑战。在本研究中,我们通过比较不同年龄组的自体胸主动脉(TA)和股动脉(FPA)的粘弹性力学,旨在揭示这些适应过程。我们将最初针对 FPA 开发的分数粘弹性框架扩展到这两种类型的动脉。为了评估这一框架,我们分析了来自 21 个年龄在 13 到 73 岁之间的人的 TA 和 FPA 标本的实验力学数据。每个标本都进行了多比率双轴机械伸展和松弛测试,并辅以双向组织学检查,以量化结构密度和微结构取向。我们的新构成模型准确地捕捉到了组织的机械响应和微观结构差异,并与实验测量的密度非常吻合。研究发现,FPA 和 TA 中胶原蛋白和平滑肌细胞(SMC)的粘弹性随年龄增长保持一致,但 FPA 中 SMC 的粘弹性是 TA 的两倍。此外,TA 和 FPA 的胶原非线性随年龄的变化也相似。该模型为动脉机械生理学以及病理条件对血管生物力学的影响提供了宝贵的见解。意义说明:要开发出治疗动脉疾病的持久疗法,就必须更深入地了解机械特性是如何随着年龄的增长在机械环境中发生演变的。在这项工作中,我们为弹性动脉和肌肉动脉开发了一个广义粘弹性构成模型,并分析了 21 名年龄在 13 到 73 岁之间的捐献者的胸主动脉(TA)和股动脉(FPA)。得出的参数与组织学有很好的相关性,可以进一步研究粘弹性是如何随年龄演变的。同一供体的 TA 和 FPA 之间的相关性表明,FPA 的粘弹性可能受到 TA 的影响,因此有必要进行更详细的分析。总之,我们的新模型被证明是研究动脉机械生理学和探索病理影响的宝贵工具。
{"title":"A viscoelastic constitutive framework for aging muscular and elastic arteries","authors":"Will Zhang ,&nbsp;Majid Jadidi ,&nbsp;Sayed Ahmadreza Razian ,&nbsp;Gerhard A. Holzapfel ,&nbsp;Alexey Kamenskiy ,&nbsp;David A. Nordsletten","doi":"10.1016/j.actbio.2024.09.021","DOIUrl":"10.1016/j.actbio.2024.09.021","url":null,"abstract":"<div><div>The evolution of arterial biomechanics and microstructure with age and disease plays a critical role in understanding the health and function of the cardiovascular system. Accurately capturing these adaptative processes and their effects on the mechanical environment is critical for predicting arterial responses. This challenge is exacerbated by the significant differences between elastic and muscular arteries, which have different structural organizations and functional demands. In this study, we aim to shed light to these adaptive processes by comparing the viscoelastic mechanics of autologous thoracic aortas (TA) and femoropopliteal arteries (FPA) in different age groups. We have extended our fractional viscoelastic framework, originally developed for FPA, to both types of arteries. To evaluate this framework, we analyzed experimental mechanical data from TA and FPA specimens from 21 individuals aged 13 to 73 years. Each specimen was subjected to a multi-ratio biaxial mechanical extension and relaxation test complemented by bidirectional histology to quantify the structural density and microstructural orientations. Our new constitutive model accurately captured the mechanical responses and microstructural differences of the tissues and closely matched the experimentally measured densities. It was found that the viscoelastic properties of collagen and smooth muscle cells (SMCs) in both the FPA and TA remained consistent with age, but the viscoelasticity of the SMCs in the FPA was twice that of the TA. Additionally, changes in collagen nonlinearity with age were similar in both TA and FPA. This model provides valuable insights into arterial mechanophysiology and the effects of pathological conditions on vascular biomechanics.</div></div><div><h3>Statement of significance</h3><div>Developing durable treatments for arterial diseases necessitates a deeper understanding of how mechanical properties evolve with age in response to mechanical environments. In this work, we developed a generalized viscoelastic constitutive model for both elastic and muscular arteries and analyzed both the thoracic aorta (TA) and the femoropopliteal artery (FPA) from 21 donors aged 13 to 73. The derived parameters correlate well with histology, allowing further examination of how viscoelasticity evolves with age. Correlation between the TA and FPA of the same donors suggest that the viscoelasticity of the FPA may be influenced by the TA, necessitating more detailed analysis. In summary, our new model proves to be a valuable tool for studying arterial mechanophysiology and exploring pathological impacts.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 223-241"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging microfluidic gut-on-a-chip systems for drug development 用于药物开发的新兴微流控芯片肠道系统。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.012
Xueqi Wang , Yuzhuo Zhu , Zhaoming Cheng , Chuanjun Zhang , Yumeng Liao , Boshi Liu , Di Zhang , Zheng Li , Yuxin Fang
The gut is a vital organ that is central to the absorption and metabolic processing of orally administered drugs. While there have been many models developed with the goal of studying the absorption of drugs in the gut, these models fail to adequately recapitulate the diverse, complex gastrointestinal microenvironment. The recent emergence of microfluidic organ-on-a-chip technologies has provided a novel means of modeling the gut, yielding radical new insights into the structure of the gut and the mechanisms through which it shapes disease, with key implications for biomedical developmental efforts. Such organ-on-a-chip technologies have been demonstrated to exhibit greater cost-effectiveness, fewer ethical concerns, and a better ability to address inter-species differences in traditional animal models in the context of drug development. The present review offers an overview of recent developments in the reconstruction of gut structure and function in vitro using microfluidic gut-on-a-chip (GOC) systems, together with a discussion of the potential applications of these platforms in the context of drug development and the challenges and future prospects associated with this technology.

Statement of significance

This paper outlines the characteristics of the different cell types most frequently used to construct microfluidic gut-on-a-chip models and the microfluidic devices employed for the study of drug absorption. And the applications of gut-related multichip coupling and disease modelling in the context of drug development is systematically reviewed. With the detailed summarization of microfluidic chip-based gut models and discussion of the prospective directions for practical application, this review will provide insights to the innovative design and application of microfluidic gut-on-a-chip for drug development.
肠道是口服药物吸收和代谢处理的重要器官。虽然已经开发了许多以研究肠道药物吸收为目标的模型,但这些模型未能充分再现多样、复杂的胃肠道微环境。最近出现的微流控芯片器官技术为肠道建模提供了一种新的手段,使人们对肠道结构及其影响疾病的机制有了全新的认识,对生物医学发展工作产生了重要影响。此类芯片器官技术已被证明具有更高的成本效益、更少的伦理问题,而且在药物开发方面能更好地应对传统动物模型的物种间差异。本综述概述了使用微流控芯片肠道(GOC)系统在体外重建肠道结构和功能的最新进展,并讨论了这些平台在药物开发中的潜在应用以及与该技术相关的挑战和未来前景。意义说明:本文概述了最常用于构建微流控芯片肠道模型的不同细胞类型的特征,以及用于药物吸收研究的微流控装置。并系统回顾了与肠道相关的多芯片耦合和疾病建模在药物开发中的应用。本综述详细总结了基于微流控芯片的肠道模型,并讨论了实际应用的前瞻性方向,将为药物开发中微流控芯片肠道的创新设计和应用提供启示。
{"title":"Emerging microfluidic gut-on-a-chip systems for drug development","authors":"Xueqi Wang ,&nbsp;Yuzhuo Zhu ,&nbsp;Zhaoming Cheng ,&nbsp;Chuanjun Zhang ,&nbsp;Yumeng Liao ,&nbsp;Boshi Liu ,&nbsp;Di Zhang ,&nbsp;Zheng Li ,&nbsp;Yuxin Fang","doi":"10.1016/j.actbio.2024.09.012","DOIUrl":"10.1016/j.actbio.2024.09.012","url":null,"abstract":"<div><div>The gut is a vital organ that is central to the absorption and metabolic processing of orally administered drugs. While there have been many models developed with the goal of studying the absorption of drugs in the gut, these models fail to adequately recapitulate the diverse, complex gastrointestinal microenvironment. The recent emergence of microfluidic organ-on-a-chip technologies has provided a novel means of modeling the gut, yielding radical new insights into the structure of the gut and the mechanisms through which it shapes disease, with key implications for biomedical developmental efforts. Such organ-on-a-chip technologies have been demonstrated to exhibit greater cost-effectiveness, fewer ethical concerns, and a better ability to address inter-species differences in traditional animal models in the context of drug development. The present review offers an overview of recent developments in the reconstruction of gut structure and function <em>in vitro</em> using microfluidic gut-on-a-chip (GOC) systems, together with a discussion of the potential applications of these platforms in the context of drug development and the challenges and future prospects associated with this technology.</div></div><div><h3>Statement of significance</h3><div>This paper outlines the characteristics of the different cell types most frequently used to construct microfluidic gut-on-a-chip models and the microfluidic devices employed for the study of drug absorption. And the applications of gut-related multichip coupling and disease modelling in the context of drug development is systematically reviewed. With the detailed summarization of microfluidic chip-based gut models and discussion of the prospective directions for practical application, this review will provide insights to the innovative design and application of microfluidic gut-on-a-chip for drug development.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 48-64"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mussel-inspired bifunctional coating for long-term stability of oral implants 由贻贝启发的双功能涂层可实现口腔植入物的长期稳定性。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.010
Mengmeng Wang , Jie Li , Mengqian Geng , Zhen Yang , Aiwen Xi , Yingying Yu , Bin Liu , Franklin R. Tay , Yaping Gou
Peri-implantitis and osseointegration failure present considerable challenges to the prolonged stability of oral implants. To address these issues, there is an escalating demand for a resilient implant surface coating that seamlessly integrates antimicrobial features to combat bacteria-induced peri‑implantitis, and osteogenic properties to promote bone formation. In the present study, a bio-inspired poly(amidoamine) dendrimer (DA-PAMAM-NH2) is synthesized by utilizing a mussel protein (DA) known for its strong adherence to various materials. Conjugating DA with PAMAM-NH2, inherently endowed with antibacterial and osteogenic properties, results in a robust and multifunctional coating. Robust adhesion between DA-PAMAM-NH2 and the titanium alloy surface is identified using confocal laser scanning microscopy (CLSM) and attenuated total reflectance-infrared (ATR-IR) spectroscopy. Following a four-week immersion of the coated titanium alloy surface in simulated body fluid (SBF), the antimicrobial activity and superior osteogenesis of the DA-PAMAM-NH2-coated surface remain stable. In contrast, the bifunctional effects of the PAMAM-NH2-coated surface diminish after the same immersion period. In vivo animal experiments validate the enduring antimicrobial and osteogenic properties of DA-PAMAM-NH2-coated titanium alloy implants, significantly enhancing the long-term stability of the implants. This innovative coating holds promise for addressing the multifaceted challenges associated with peri‑implantitis and osseointegration failure in titanium-based implants.

Statement of significance

Prolonged stability of oral implants remains a clinically-significant challenge. Peri-implantitis and osseointegration failure are two important contributors to the poor stability of oral implants. The present study developed a mussel-bioinspired poly(amidoamine) dendrimer (DA-PAMAM-NH2) for a resilient implant surface coating that seamlessly integrates antimicrobial features to combat bacteria-induced peri‑implantitis, and osteogenic properties to promote bone formation to extend the longevity of oral implants.
种植体周围炎和骨结合失败给口腔种植体的长期稳定性带来了巨大挑战。为了解决这些问题,人们对弹性种植体表面涂层的需求不断增加,这种涂层既要具有抗菌功能以对抗细菌引起的种植体周围炎,又要具有成骨特性以促进骨形成。本研究利用贻贝蛋白(DA)合成了一种生物启发聚(氨基胺)树枝状聚合物(DA-PAMAM-NH2),DA 因其对各种材料的强粘附性而闻名。PAMAM-NH2 本身具有抗菌和成骨特性,将 DA 与 PAMAM-NH2 共轭,可制成坚固耐用的多功能涂层。使用共焦激光扫描显微镜(CLSM)和衰减全反射红外光谱(ATR-IR)确定了 DA-PAMAM-NH2 与钛合金表面之间的牢固粘附性。涂层钛合金表面在模拟体液(SBF)中浸泡四周后,DA-PAMAM-NH2 涂层表面的抗菌活性和优异的成骨能力保持稳定。相比之下,PAMAM-NH2 涂层表面的双功能效果在相同的浸泡时间后会减弱。体内动物实验验证了 DA-PAMAM-NH2 涂层钛合金植入体的持久抗菌和成骨特性,显著提高了植入体的长期稳定性。这种创新涂层有望解决与钛基植入物种植体周围炎和骨结合失败相关的多方面挑战。意义说明:口腔种植体的长期稳定性仍然是临床上的一个重大挑战。种植体周围炎和骨结合失败是导致口腔种植体稳定性差的两个重要原因。本研究开发了一种由贻贝生物启发的聚(氨基胺)树枝状聚合物(DA-PAMAM-NH2),用于弹性种植体表面涂层,该涂层无缝整合了抗菌特性和成骨特性,前者可抗击细菌引起的种植体周围炎,后者可促进骨形成,从而延长口腔种植体的寿命。
{"title":"Mussel-inspired bifunctional coating for long-term stability of oral implants","authors":"Mengmeng Wang ,&nbsp;Jie Li ,&nbsp;Mengqian Geng ,&nbsp;Zhen Yang ,&nbsp;Aiwen Xi ,&nbsp;Yingying Yu ,&nbsp;Bin Liu ,&nbsp;Franklin R. Tay ,&nbsp;Yaping Gou","doi":"10.1016/j.actbio.2024.09.010","DOIUrl":"10.1016/j.actbio.2024.09.010","url":null,"abstract":"<div><div>Peri-implantitis and osseointegration failure present considerable challenges to the prolonged stability of oral implants. To address these issues, there is an escalating demand for a resilient implant surface coating that seamlessly integrates antimicrobial features to combat bacteria-induced peri‑implantitis, and osteogenic properties to promote bone formation. In the present study, a bio-inspired poly(amidoamine) dendrimer (DA-PAMAM-NH<sub>2</sub>) is synthesized by utilizing a mussel protein (DA) known for its strong adherence to various materials. Conjugating DA with PAMAM-NH<sub>2</sub>, inherently endowed with antibacterial and osteogenic properties, results in a robust and multifunctional coating. Robust adhesion between DA-PAMAM-NH<sub>2</sub> and the titanium alloy surface is identified using confocal laser scanning microscopy (CLSM) and attenuated total reflectance-infrared (ATR-IR) spectroscopy. Following a four-week immersion of the coated titanium alloy surface in simulated body fluid (SBF), the antimicrobial activity and superior osteogenesis of the DA-PAMAM-NH<sub>2</sub>-coated surface remain stable. In contrast, the bifunctional effects of the PAMAM-NH<sub>2</sub>-coated surface diminish after the same immersion period. In vivo animal experiments validate the enduring antimicrobial and osteogenic properties of DA-PAMAM-NH<sub>2</sub>-coated titanium alloy implants, significantly enhancing the long-term stability of the implants. This innovative coating holds promise for addressing the multifaceted challenges associated with peri‑implantitis and osseointegration failure in titanium-based implants.</div></div><div><h3>Statement of significance</h3><div>Prolonged stability of oral implants remains a clinically-significant challenge. Peri-implantitis and osseointegration failure are two important contributors to the poor stability of oral implants. The present study developed a mussel-bioinspired poly(amidoamine) dendrimer (DA-PAMAM-NH<sub>2</sub>) for a resilient implant surface coating that seamlessly integrates antimicrobial features to combat bacteria-induced peri‑implantitis, and osteogenic properties to promote bone formation to extend the longevity of oral implants.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 138-156"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D-ink-extruded titanium scaffolds with porous struts and bioactive supramolecular polymers for orthopedic implants 具有多孔支柱和生物活性超分子聚合物的三维墨水挤压钛支架,用于骨科植入物。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.004
John P. Misiaszek , Nicholas A. Sather , Alyssa M. Goodwin , Hogan J. Brecount , Steven S. Kurapaty , Jacqueline E. Inglis , Erin L. Hsu , Samuel I. Stupp , Stuart R. Stock , David C. Dunand
Porous titanium addresses the longstanding orthopedic challenges of aseptic loosening and stress shielding. This work expands on the evolution of porous Ti with the manufacturing of hierarchically porous, low stiffness, ductile Ti scaffolds via direct-ink write (DIW) extrusion and sintering of inks containing Ti and NaCl particles. Scaffold macrochannels were filled with a subtherapeutic dose of recombinant bone morphogenetic protein-2 (rhBMP-2) alone or co-delivered within a bioactive supramolecular polymer slurry (SPS) composed of peptide amphiphile nanofibrils and collagen, creating four treatment conditions (Ti struts: microporous vs. fully dense; BMP-2 alone or with SPS). The BMP-2-loaded scaffolds were implanted bilaterally across the L4 and L5 transverse processes in a rat posterolateral lumbar fusion model. In-vivo bone growth in these scaffolds is evaluated with synchrotron X-ray computed microtomography (µCT) to study the effects of strut microporosity and added biological signaling agents on the bone formation response. Optical and scanning electron microscopy confirms the ∼100 µm space-holder micropore size, high-curvature morphology, and pore fenestrations within the struts. Uniaxial compression testing shows that the microporous strut scaffolds have low stiffness and high ductility. A significant promotion in bone formation was observed for groups utilizing the SPS, while no significant differences were found for the scaffolds with the incorporation of micropores.

Statement of significance

By 2050, the anticipated number of people aged 60 years and older worldwide is anticipated to double to 2.1 billion. This rapid increase in the geriatric population will require a corresponding increase in orthopedic surgeries and more effective materials for longer indwelling times. Titanium alloys have been the gold standard of bone fusion and fixation, but their use has longstanding limitations in bone-implant stiffness mismatch and insufficient osseointegration. We utilize 3D-printing of titanium with NaCl space holders for large- and small-scale porosity and incorporate bioactive supramolecular polymers into the scaffolds to increase bone growth. This work finds no significant change in bone ingrowth via space-holder-induced microporosity but significant increases in bone ingrowth via the bioactive supramolecular polymers in a rat posterolateral fusion model.
多孔钛解决了整形外科长期以来面临的无菌松动和应力屏蔽难题。这项研究拓展了多孔钛的发展,通过直接墨水写入(DIW)挤压和烧结含有钛和氯化钠颗粒的墨水,制造出分层多孔、低刚度、韧性好的钛支架。在支架大通道中单独填充亚治疗剂量的重组骨形态发生蛋白-2(rhBMP-2),或在由肽两性纳米纤维和胶原蛋白组成的生物活性超分子聚合物浆料(SPS)中共同填充重组骨形态发生蛋白-2,形成四种处理条件(钛支架:微孔与全致密;单独或与 SPS)。在大鼠后外侧腰椎融合模型中,将 BMP-2 负载支架横跨 L4 和 L5 横向椎体植入双侧。利用同步辐射 X 射线计算机显微层析技术(µCT)评估了这些支架的体内骨生长情况,以研究支柱微孔和添加的生物信号物质对骨形成反应的影响。光学显微镜和扫描电子显微镜证实了支撑杆内∼100 微米的空间夹层微孔尺寸、高曲率形态和孔隙。单轴压缩测试表明,微孔支架具有低刚度和高延展性。在使用 SPS 的组别中,骨形成有明显的促进作用,而加入微孔的支架则没有发现明显的差异。意义说明:到 2050 年,全球 60 岁及以上人口预计将翻一番,达到 21 亿。老年人口的快速增长将要求骨科手术的数量相应增加,并需要更有效的材料来延长留置时间。钛合金一直是骨融合和固定的黄金标准,但其使用长期以来存在骨-植入物刚度不匹配和骨结合不足的局限性。我们利用三维打印技术将钛与氯化钠空间支架结合,以获得大尺度和小尺度的孔隙率,并在支架中加入生物活性超分子聚合物,以增加骨生长。这项研究发现,在大鼠后外侧融合模型中,通过空间支架诱导的微孔对骨生长没有明显影响,但通过生物活性超分子聚合物对骨生长有明显增加。
{"title":"3D-ink-extruded titanium scaffolds with porous struts and bioactive supramolecular polymers for orthopedic implants","authors":"John P. Misiaszek ,&nbsp;Nicholas A. Sather ,&nbsp;Alyssa M. Goodwin ,&nbsp;Hogan J. Brecount ,&nbsp;Steven S. Kurapaty ,&nbsp;Jacqueline E. Inglis ,&nbsp;Erin L. Hsu ,&nbsp;Samuel I. Stupp ,&nbsp;Stuart R. Stock ,&nbsp;David C. Dunand","doi":"10.1016/j.actbio.2024.09.004","DOIUrl":"10.1016/j.actbio.2024.09.004","url":null,"abstract":"<div><div>Porous titanium addresses the longstanding orthopedic challenges of aseptic loosening and stress shielding. This work expands on the evolution of porous Ti with the manufacturing of hierarchically porous, low stiffness, ductile Ti scaffolds via direct-ink write (DIW) extrusion and sintering of inks containing Ti and NaCl particles. Scaffold macrochannels were filled with a subtherapeutic dose of recombinant bone morphogenetic protein-2 (rhBMP-2) alone or co-delivered within a bioactive supramolecular polymer slurry (SPS) composed of peptide amphiphile nanofibrils and collagen, creating four treatment conditions (Ti struts: microporous vs. fully dense; BMP-2 alone or with SPS). The BMP-2-loaded scaffolds were implanted bilaterally across the L4 and L5 transverse processes in a rat posterolateral lumbar fusion model. In-vivo bone growth in these scaffolds is evaluated with synchrotron X-ray computed microtomography (µCT) to study the effects of strut microporosity and added biological signaling agents on the bone formation response. Optical and scanning electron microscopy confirms the ∼100 µm space-holder micropore size, high-curvature morphology, and pore fenestrations within the struts. Uniaxial compression testing shows that the microporous strut scaffolds have low stiffness and high ductility. A significant promotion in bone formation was observed for groups utilizing the SPS, while no significant differences were found for the scaffolds with the incorporation of micropores.</div></div><div><h3>Statement of significance</h3><div>By 2050, the anticipated number of people aged 60 years and older worldwide is anticipated to double to 2.1 billion. This rapid increase in the geriatric population will require a corresponding increase in orthopedic surgeries and more effective materials for longer indwelling times. Titanium alloys have been the gold standard of bone fusion and fixation, but their use has longstanding limitations in bone-implant stiffness mismatch and insufficient osseointegration. We utilize 3D-printing of titanium with NaCl space holders for large- and small-scale porosity and incorporate bioactive supramolecular polymers into the scaffolds to increase bone growth. This work finds no significant change in bone ingrowth via space-holder-induced microporosity but significant increases in bone ingrowth via the bioactive supramolecular polymers in a rat posterolateral fusion model.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 446-459"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of pediatric porcine pulmonary valves as a model for tissue engineered heart valves 作为组织工程心脏瓣膜模型的小儿猪肺动脉瓣的特征。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.08.050
Shouka Parvin Nejad , Bahram Mirani , Zahra Mirzaei , Craig A. Simmons
Heart valve tissue engineering holds the potential to transform the surgical management of congenital heart defects affecting the pediatric pulmonary valve (PV) by offering a viable valve replacement. While aiming to recapitulate the native valve, the minimum requirement for tissue engineered heart valves (TEHVs) has historically been adequate mechanical function at implantation. However, long-term in situ functionality of TEHVs remains elusive, suggesting that a closer approximation of the native valve is required. The realization of biomimetic engineered pediatric PV is impeded by insufficient characterization of healthy pediatric tissue. In this study, we comprehensively characterized the planar biaxial tensile behaviour, extracellular matrix (ECM) composition and organization, and valvular interstitial cell (VIC) phenotypes of PVs from piglets to provide benchmarks for TEHVs. The piglet PV possessed an anisotropic and non-linear tension-strain profile from which material constants for a predictive constitutive model were derived. The ECM of the piglet PV possessed a trilayer organization populated by collagen, glycosaminoglycans, and elastin. Biochemical quantification of ECM content normalized to wet weight and DNA content of PV tissue revealed homogeneous distribution across sampled regions of the leaflet. Finally, VICs in the piglet PV were primarily quiescent vimentin-expressing fibroblasts, with a small proportion of activated α-smooth muscle actin-expressing myofibroblasts. Overall, piglet PV properties were consistent with those reported anecdotally for pediatric human PVs and distinct from those of adult porcine and human PVs, supporting the utility of the properties determined here to inform the design of tissue engineered pediatric PVs.

Statement of significance

Heart valve tissue engineering has the potential to transform treatment for children born with defective pulmonary valves by providing living replacement tissue that can grow with the child. The design of tissue engineered heart valves is best informed by native valve properties, but native pediatric pulmonary valves have not been fully described to date. Here, we provide comprehensive characterization of the planar biaxial tensile behaviour, extracellular matrix composition and organization, and valvular interstitial cell phenotypes of pulmonary valves from piglets as a model for the native human pediatric valve. Together, these findings provide standards that inform engineered heart valve design towards generation of biomimetic pediatric pulmonary valves.
心脏瓣膜组织工程通过提供一种可行的瓣膜替代物,有望改变影响小儿肺动脉瓣(PV)的先天性心脏缺陷的外科治疗。组织工程心脏瓣膜(TEHVs)的目标是再现原生瓣膜,其最低要求历来是在植入时具有足够的机械功能。然而,组织工程心脏瓣膜的长期原位功能仍难以实现,这表明需要更接近原生瓣膜。健康儿科组织的特征描述不足阻碍了生物仿生工程儿科瓣膜的实现。在这项研究中,我们全面描述了小猪瓣膜的平面双轴拉伸行为、细胞外基质(ECM)的组成和组织以及瓣膜间质细胞(VIC)的表型,为 TEHV 提供了基准。仔猪瓣膜具有各向异性和非线性的张力-应变曲线,据此可推导出预测构成模型的材料常数。仔猪腹膜的 ECM 具有三层组织,由胶原蛋白、糖胺聚糖和弹性蛋白组成。根据湿重和 PV 组织 DNA 含量对 ECM 含量进行归一化的生化定量分析显示,ECM 在小叶取样区域内分布均匀。最后,仔猪肺泡中的 VIC 主要是表达波形蛋白的静止成纤维细胞,还有一小部分活化的表达α-平滑肌肌动蛋白的肌成纤维细胞。总体而言,仔猪肺泡的特性与坊间报道的小儿人类肺泡的特性一致,而与成年猪和人类肺泡的特性不同,这支持了本文所确定的特性在设计组织工程小儿肺泡时的实用性。意义声明:心脏瓣膜组织工程有可能改变先天性肺动脉瓣缺损儿童的治疗方法,因为它能提供可与儿童一起生长的活体替代组织。组织工程心脏瓣膜的设计最好参考原生瓣膜的特性,但迄今为止对原生小儿肺动脉瓣的描述并不全面。在这里,我们对作为原生人类小儿瓣膜模型的仔猪肺动脉瓣的平面双轴拉伸行为、细胞外基质组成和组织以及瓣膜间质细胞表型进行了全面描述。这些研究结果为工程心脏瓣膜的设计提供了标准,有助于生成生物仿生小儿肺动脉瓣。
{"title":"Characterization of pediatric porcine pulmonary valves as a model for tissue engineered heart valves","authors":"Shouka Parvin Nejad ,&nbsp;Bahram Mirani ,&nbsp;Zahra Mirzaei ,&nbsp;Craig A. Simmons","doi":"10.1016/j.actbio.2024.08.050","DOIUrl":"10.1016/j.actbio.2024.08.050","url":null,"abstract":"<div><div>Heart valve tissue engineering holds the potential to transform the surgical management of congenital heart defects affecting the pediatric pulmonary valve (PV) by offering a viable valve replacement. While aiming to recapitulate the native valve, the minimum requirement for tissue engineered heart valves (TEHVs) has historically been adequate mechanical function at implantation. However, long-term in situ functionality of TEHVs remains elusive, suggesting that a closer approximation of the native valve is required. The realization of biomimetic engineered pediatric PV is impeded by insufficient characterization of healthy pediatric tissue. In this study, we comprehensively characterized the planar biaxial tensile behaviour, extracellular matrix (ECM) composition and organization, and valvular interstitial cell (VIC) phenotypes of PVs from piglets to provide benchmarks for TEHVs. The piglet PV possessed an anisotropic and non-linear tension-strain profile from which material constants for a predictive constitutive model were derived. The ECM of the piglet PV possessed a trilayer organization populated by collagen, glycosaminoglycans, and elastin. Biochemical quantification of ECM content normalized to wet weight and DNA content of PV tissue revealed homogeneous distribution across sampled regions of the leaflet. Finally, VICs in the piglet PV were primarily quiescent vimentin-expressing fibroblasts, with a small proportion of activated α-smooth muscle actin-expressing myofibroblasts. Overall, piglet PV properties were consistent with those reported anecdotally for pediatric human PVs and distinct from those of adult porcine and human PVs, supporting the utility of the properties determined here to inform the design of tissue engineered pediatric PVs.</div></div><div><h3>Statement of significance</h3><div>Heart valve tissue engineering has the potential to transform treatment for children born with defective pulmonary valves by providing living replacement tissue that can grow with the child. The design of tissue engineered heart valves is best informed by native valve properties, but native pediatric pulmonary valves have not been fully described to date. Here, we provide comprehensive characterization of the planar biaxial tensile behaviour, extracellular matrix composition and organization, and valvular interstitial cell phenotypes of pulmonary valves from piglets as a model for the native human pediatric valve. Together, these findings provide standards that inform engineered heart valve design towards generation of biomimetic pediatric pulmonary valves.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 242-252"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Induced pluripotent stem cell-derived neural stem cells promote bone formation in mice with calvarial defects 诱导多能干细胞衍生的神经干细胞可促进腓骨缺损小鼠的骨形成。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.08.054
Yukari Shiwaku , Hiroko Okawa , Ikuro Suzuki , Susumu Sakai , Hiroshi Egusa , Osamu Suzuki
Nerve-derived factors have attracted attention in bone regeneration therapy due to their ability to promote bone regeneration and nerve innervation. Mesenchymal stem cells transported to target sites promote osteogenesis. However, there are few reports on the effects of neural stem cells on bone regeneration. Therefore, the aim of this study was to investigate the role of neural stem cells in osteogenesis. Here, embryoid bodies (EB) or primary neurospheres (1NS) were generated using mouse induced pluripotent stem cells (iPS cells), which were then seeded onto gelatin (Gel) sponges. The seeded Gel sponges were then transplanted into mouse calvarial bone defects. We noted that 1NS-seeded Gel promoted bone regeneration and the presence of tartrate-resistant acid phosphatase (TRAP)-positive cells, whereas the EB-seeded Gel did not. RNA-sequencing of the 1NS-seeded and EB seeded Gels showed an upregulation of the transforming growth factor (TGF)-β signaling pathway in the 1NS-seeded Gel group. Immunostaining confirmed the presence of Id3 positive cells in mice with bone defects treated with the 1NS-seeded Gel. These findings suggest that the transplantation of neural stem cells may contribute to the promotion of bone regeneration.

Statement of significance

This study aimed to investigate whether neural stem cells, when seeded in Gel sponges, promoted bone regeneration. It has been well documented that bone is tightly linked with the nervous systems. Bioscaffolds comprising factors that promote innervation and bone regeneration have been investigated for use in bone therapy. However, there is limited research on the use of neural stem cells for promoting bone formation. To assess this relationship, we conducted both in vivo and in vitro assays to determine whether neural stem cells promoted bone formation. We noted that 1NS-seeded Gel sponges promoted bone formation significantly in mice with calvarial defects after 4 weeks. This study provides a novel approach of neural stem cells for bone therapy.
神经源因子具有促进骨再生和神经支配的能力,因此在骨再生疗法中备受关注。间充质干细胞运输到目标部位可促进骨生成。然而,有关神经干细胞对骨再生影响的报道却很少。因此,本研究旨在探讨神经干细胞在骨生成中的作用。本研究利用小鼠诱导多能干细胞(iPS细胞)生成类胚体(EB)或初级神经球(1NS),然后将其播种到明胶(Gel)海绵上。然后将播种的明胶海绵移植到小鼠腓骨缺损处。我们注意到 1NS 种子凝胶促进了骨再生和 TRAP 阳性细胞的出现,而 EB 种子凝胶则没有。对 1NS 种子凝胶和 EB 种子凝胶进行的 RNA 序列分析表明,在 1NS 种子凝胶组中,TGF-β 信号通路上调。免疫染色证实,使用1NS种子凝胶治疗骨缺损的小鼠体内存在Id3阳性细胞。这些发现表明,移植神经干细胞可能有助于促进骨再生。意义说明:本研究旨在探讨神经干细胞在明胶海绵中播种是否能促进骨再生。有大量文献表明,骨骼与神经系统密切相关。研究人员已将含有促进神经支配和骨再生因子的生物支架用于骨治疗。然而,有关使用神经干细胞促进骨形成的研究却很有限。为了评估这种关系,我们进行了体内和体外试验,以确定神经干细胞是否促进骨形成。我们注意到,原代神经球播种明胶海绵在四周后能显著促进腓骨缺损小鼠的骨形成。这项研究提供了神经干细胞用于骨治疗的新方法。
{"title":"Induced pluripotent stem cell-derived neural stem cells promote bone formation in mice with calvarial defects","authors":"Yukari Shiwaku ,&nbsp;Hiroko Okawa ,&nbsp;Ikuro Suzuki ,&nbsp;Susumu Sakai ,&nbsp;Hiroshi Egusa ,&nbsp;Osamu Suzuki","doi":"10.1016/j.actbio.2024.08.054","DOIUrl":"10.1016/j.actbio.2024.08.054","url":null,"abstract":"<div><div>Nerve-derived factors have attracted attention in bone regeneration therapy due to their ability to promote bone regeneration and nerve innervation. Mesenchymal stem cells transported to target sites promote osteogenesis. However, there are few reports on the effects of neural stem cells on bone regeneration. Therefore, the aim of this study was to investigate the role of neural stem cells in osteogenesis. Here, embryoid bodies (EB) or primary neurospheres (1NS) were generated using mouse induced pluripotent stem cells (iPS cells), which were then seeded onto gelatin (Gel) sponges. The seeded Gel sponges were then transplanted into mouse calvarial bone defects. We noted that 1NS-seeded Gel promoted bone regeneration and the presence of tartrate-resistant acid phosphatase (TRAP)-positive cells, whereas the EB-seeded Gel did not. RNA-sequencing of the 1NS-seeded and EB seeded Gels showed an upregulation of the transforming growth factor (TGF)-β signaling pathway in the 1NS-seeded Gel group. Immunostaining confirmed the presence of Id3 positive cells in mice with bone defects treated with the 1NS-seeded Gel. These findings suggest that the transplantation of neural stem cells may contribute to the promotion of bone regeneration.</div></div><div><h3>Statement of significance</h3><div>This study aimed to investigate whether neural stem cells, when seeded in Gel sponges, promoted bone regeneration. It has been well documented that bone is tightly linked with the nervous systems. Bioscaffolds comprising factors that promote innervation and bone regeneration have been investigated for use in bone therapy. However, there is limited research on the use of neural stem cells for promoting bone formation. To assess this relationship, we conducted both <em>in vivo</em> and <em>in vitro</em> assays to determine whether neural stem cells promoted bone formation. We noted that 1NS-seeded Gel sponges promoted bone formation significantly in mice with calvarial defects after 4 weeks. This study provides a novel approach of neural stem cells for bone therapy.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 93-102"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142147079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis, characterization, and surface modification of degradable polar hydrophobic ionic polyurethane nanoparticles for the delivery of therapeutics to vascular tissue 用于向血管组织输送治疗药物的可降解极性疏水性离子聚氨酯纳米粒子的合成、表征和表面修饰。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.024
Chantal M. Trepanier , Jonathan Rubianto , Jonah Burke-Kleinman , Ryan Appings , Michelle P. Bendeck , J. Paul Santerre
Degradable polar hydrophobic ionic polyurethanes (D-PHI) are an emerging class of biomaterials with particular significance for blood-contacting applications due to their immunomodulatory effects and highly customizable block chemistry. In this manuscript, D-PHI polymer was formulated as a nanoparticle excipient for the first time by inverse emulsion polymerization. The nanoparticles were optimized with consideration of diameter, surface charge, size variability, and yield as a delivery vehicle for a custom vascular therapeutic peptide. A layer-by-layer (LBL) surface modification technique using poly-L-lysine was integrated within the nanoparticle design to optimize therapeutic loading efficiency. Solvent pH played a pivotal role in emulsion micelle formation, LBL polymer secondary structure, and the polymer functional group interactions critical for high therapeutic loading. The resulting nanoparticle platform met target size (200 ± 20 nm), polydispersity (<0.07), and storage stability standards, was nontoxic, and did not affect therapeutic peptide bioactivity in vitro. Surface-modified D-PHI nanoparticles can be reproducibly manufactured at low cost, generating a highly customizable excipient platform suitable for delivery of biomolecular therapeutics. These nanoparticles have potential applications in vascular drug delivery via localized infusion, drug eluting stents, and drug-coated angioplasty balloons.

Statement of significance

Nanoscale excipients have become critical in the delivery of many therapeutics to enhance drug stability and targeted biodistribution through careful design of nanoparticle composition, surface chemistry, and size. This manuscript describes the development of a nanoparticle excipient derived from an immunomodulatory degradable polar hydrophobic ionic polyurethane, in combination with a layer-by-layer surface modification approach utilizing poly-L-lysine, to transport a mimetic peptide targeting smooth muscle cell migration in vascular disease. The nanoparticle platform draws on the effect of pH to maximize drug loading and tailor particle properties. The low cost and easily reproducible system presents a highly customizable platform that can be adapted for therapeutic delivery across a wide range of clinical indications.
可降解极性疏水性离子聚氨酯(D-PHI)是一类新兴的生物材料,由于其免疫调节作用和高度可定制的嵌段化学性质,对血液接触应用具有特别重要的意义。本手稿首次采用反乳液聚合法将 D-PHI 聚合物配制成纳米颗粒赋形剂。考虑到纳米颗粒的直径、表面电荷、尺寸可变性和产量,对其进行了优化,使其成为定制血管治疗肽的输送载体。在纳米颗粒设计中采用了聚 L-赖氨酸逐层(LBL)表面修饰技术,以优化治疗负载效率。溶剂的 pH 值对乳液胶束的形成、LBL 聚合物的二级结构以及对高治疗负荷至关重要的聚合物官能团相互作用起着关键作用。由此产生的纳米粒子平台达到了目标尺寸(200 ± 20 nm)、多分散性(0.1%)和治疗效率(0.1%)。
{"title":"Synthesis, characterization, and surface modification of degradable polar hydrophobic ionic polyurethane nanoparticles for the delivery of therapeutics to vascular tissue","authors":"Chantal M. Trepanier ,&nbsp;Jonathan Rubianto ,&nbsp;Jonah Burke-Kleinman ,&nbsp;Ryan Appings ,&nbsp;Michelle P. Bendeck ,&nbsp;J. Paul Santerre","doi":"10.1016/j.actbio.2024.09.024","DOIUrl":"10.1016/j.actbio.2024.09.024","url":null,"abstract":"<div><div>Degradable polar hydrophobic ionic polyurethanes (D-PHI) are an emerging class of biomaterials with particular significance for blood-contacting applications due to their immunomodulatory effects and highly customizable block chemistry. In this manuscript, D-PHI polymer was formulated as a nanoparticle excipient for the first time by inverse emulsion polymerization. The nanoparticles were optimized with consideration of diameter, surface charge, size variability, and yield as a delivery vehicle for a custom vascular therapeutic peptide. A layer-by-layer (LBL) surface modification technique using poly-L-lysine was integrated within the nanoparticle design to optimize therapeutic loading efficiency. Solvent pH played a pivotal role in emulsion micelle formation, LBL polymer secondary structure, and the polymer functional group interactions critical for high therapeutic loading. The resulting nanoparticle platform met target size (200 ± 20 nm), polydispersity (&lt;0.07), and storage stability standards, was nontoxic, and did not affect therapeutic peptide bioactivity <em>in vitro.</em> Surface-modified D-PHI nanoparticles can be reproducibly manufactured at low cost, generating a highly customizable excipient platform suitable for delivery of biomolecular therapeutics. These nanoparticles have potential applications in vascular drug delivery via localized infusion, drug eluting stents, and drug-coated angioplasty balloons.</div></div><div><h3>Statement of significance</h3><div>Nanoscale excipients have become critical in the delivery of many therapeutics to enhance drug stability and targeted biodistribution through careful design of nanoparticle composition, surface chemistry, and size. This manuscript describes the development of a nanoparticle excipient derived from an immunomodulatory degradable polar hydrophobic ionic polyurethane, in combination with a layer-by-layer surface modification approach utilizing poly-L-lysine, to transport a mimetic peptide targeting smooth muscle cell migration in vascular disease. The nanoparticle platform draws on the effect of pH to maximize drug loading and tailor particle properties. The low cost and easily reproducible system presents a highly customizable platform that can be adapted for therapeutic delivery across a wide range of clinical indications.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 184-196"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adoptive transfer of immunomodulatory macrophages reduces the pro-inflammatory microenvironment and increases bone formation on titanium implants 免疫调节巨噬细胞的收养性转移可降低促炎微环境并增加钛植入物上的骨形成。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-10-15 DOI: 10.1016/j.actbio.2024.09.011
Lais Morandini , Tyler Heath , Luke S. Sheakley , Derek Avery , Melissa Grabiec , Michael Friedman , Rebecca K. Martin , Jonathan Boyd , Rene Olivares-Navarrete
Macrophages play a central role in orchestrating the inflammatory response to implanted biomaterials and are sensitive to changes in the chemical and physical characteristics of the implant. Macrophages respond to biological, chemical, and physical cues by polarizing into pro-inflammatory (M1) or anti-inflammatory (M2) states. We previously showed that rough-hydrophilic titanium (Ti) implants skew macrophage polarization towards an anti-inflammatory phenotype and increase mesenchymal stem cell (MSC) recruitment and bone formation around the implant. In the present study, we aimed to investigate whether the adoptive transfer of macrophages in different polarization states would alter the inflammatory microenvironment and improve biomaterial integration in macrophage-competent and macrophage-ablated mice. We found that ablating macrophages increased the presence of neutrophils, reduced T cells and MSCs, and compromised the healing and biomaterial integration process. These effects could not be rescued with adoptive transfer of naïve or polarized macrophages. Adoptive transfer of M1 macrophages into macrophage-competent mice increased inflammatory cells and inflammatory microenvironment, resulting in decreased bone-to-implant contact. Adoptive transfer of M2 macrophages into macrophage-competent mice reduced the pro-inflammatory environment in the peri‑implant tissue and increased bone-to-implant contact. Taken together, our results show the importance of macrophages in controlling and modulating the inflammatory process in response to implanted biomaterials and suggest they can be used to improve outcomes following biomaterial implantation.

Statement of significance

Macrophages are central in orchestrating the inflammatory response to implanted biomaterials and are sensitive to biomaterial chemical and physical characteristics. Our study shows that a deficiency of macrophages results in prolonged inflammation and abolishes bone-biomaterial integration. Adoptive transfer of immunomodulatory macrophages into macrophage-competent mice reduced the inflammatory environment and increased bone-implant contact.
巨噬细胞在协调对植入生物材料的炎症反应中发挥着核心作用,并对植入物的化学和物理特性变化十分敏感。巨噬细胞对生物、化学和物理线索的反应是极化为促炎(M1)或抗炎(M2)状态。我们以前的研究表明,粗糙亲水性钛(Ti)植入物会使巨噬细胞向抗炎表型极化,并增加间充质干细胞(MSC)的招募和植入物周围的骨形成。在本研究中,我们旨在探讨不同极化状态的巨噬细胞的收养性转移是否会改变炎症微环境,并改善巨噬细胞功能健全和巨噬细胞功能缺失小鼠的生物材料整合。我们发现,消融巨噬细胞会增加中性粒细胞的存在,减少 T 细胞和间充质干细胞,并损害愈合和生物材料整合过程。这些影响无法通过收养性转移天真或极化巨噬细胞得到挽救。将 M1 巨噬细胞收养性转移到具有巨噬细胞能力的小鼠体内会增加炎症细胞和炎症微环境,导致骨与种植体接触减少。将 M2 巨噬细胞收养转移到巨噬细胞功能正常的小鼠体内可减少种植体周围组织的促炎环境,增加骨与种植体的接触。综上所述,我们的研究结果表明了巨噬细胞在控制和调节植入生物材料的炎症反应过程中的重要性,并表明巨噬细胞可用于改善生物材料植入后的治疗效果。意义说明:巨噬细胞是协调植入生物材料炎症反应的核心,对生物材料的化学和物理特性非常敏感。我们的研究表明,巨噬细胞的缺乏会导致炎症持续时间延长,并破坏骨与生物材料的整合。将具有免疫调节功能的巨噬细胞收养转移到具有巨噬细胞功能的小鼠体内可减轻炎症环境并增加骨与植入物的接触。
{"title":"Adoptive transfer of immunomodulatory macrophages reduces the pro-inflammatory microenvironment and increases bone formation on titanium implants","authors":"Lais Morandini ,&nbsp;Tyler Heath ,&nbsp;Luke S. Sheakley ,&nbsp;Derek Avery ,&nbsp;Melissa Grabiec ,&nbsp;Michael Friedman ,&nbsp;Rebecca K. Martin ,&nbsp;Jonathan Boyd ,&nbsp;Rene Olivares-Navarrete","doi":"10.1016/j.actbio.2024.09.011","DOIUrl":"10.1016/j.actbio.2024.09.011","url":null,"abstract":"<div><div>Macrophages play a central role in orchestrating the inflammatory response to implanted biomaterials and are sensitive to changes in the chemical and physical characteristics of the implant. Macrophages respond to biological, chemical, and physical cues by polarizing into pro-inflammatory (M1) or anti-inflammatory (M2) states. We previously showed that rough-hydrophilic titanium (Ti) implants skew macrophage polarization towards an anti-inflammatory phenotype and increase mesenchymal stem cell (MSC) recruitment and bone formation around the implant. In the present study, we aimed to investigate whether the adoptive transfer of macrophages in different polarization states would alter the inflammatory microenvironment and improve biomaterial integration in macrophage-competent and macrophage-ablated mice. We found that ablating macrophages increased the presence of neutrophils, reduced T cells and MSCs, and compromised the healing and biomaterial integration process. These effects could not be rescued with adoptive transfer of naïve or polarized macrophages. Adoptive transfer of M1 macrophages into macrophage-competent mice increased inflammatory cells and inflammatory microenvironment, resulting in decreased bone-to-implant contact. Adoptive transfer of M2 macrophages into macrophage-competent mice reduced the pro-inflammatory environment in the peri‑implant tissue and increased bone-to-implant contact. Taken together, our results show the importance of macrophages in controlling and modulating the inflammatory process in response to implanted biomaterials and suggest they can be used to improve outcomes following biomaterial implantation.</div></div><div><h3>Statement of significance</h3><div>Macrophages are central in orchestrating the inflammatory response to implanted biomaterials and are sensitive to biomaterial chemical and physical characteristics. Our study shows that a deficiency of macrophages results in prolonged inflammation and abolishes bone-biomaterial integration. Adoptive transfer of immunomodulatory macrophages into macrophage-competent mice reduced the inflammatory environment and increased bone-implant contact.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"188 ","pages":"Pages 432-445"},"PeriodicalIF":9.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Biomaterialia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1